Commercial GLP-1 Agonists Commercially available GLP-1 agonists are prescription therapies commonly used to support blood sugar management and weight management in appropriate patients
Tracking your response objectively, through weight measurements, appetite scores, and blood glucose monitoring, helps separate real pharmacological differences from the anxiety of change
Administration is simple and convenienttypically involving a self-administered, once-weekly injection using a pre-filled pen
The bioavailability differs, the dosing schedule changes from weekly to daily, and the evidence base is less robust
Individuals received a condition flag if they had one or more claims/encounters that matched a respective ICD-10 code mapped onto one of the Bridge clinical criteria in an inpatient, outpatient, carrier, home health, or skilled nursing facility setting in 2023
Fox BC, Devonshire AS, Schutte ME, Foy CA, Minguez J, Przyborski S, et al